Financial woes are threatening Advanced Cell Technology, running the only FDA-approved clinical trials of embryonic stem cell therapies
The fungi help prevent any one species from dominating an ecosystem
The benefits and risks of "gain-of-function" research into highly pathogenic microbes with pandemic potential must be evaluated, scientists say
"Breakthrough therapy" status is much sought after, but there is confusion about its definition and impact
Cells can be regenerated in their natural environment, without making a pit stop in a Petri dish
Warmer temperatures mean varieties such as Fuji apples are softer and sweeter than they were 40 years ago
Diabetic rats were found to control blood glucose better after undergoing the weight-loss surgery
Dense arrangements of nerves in and around tumors seems to make the cancer more aggressive in mice
Arithmetic division guides plants' use of energy at night
As the justices prepare to hear arguments in the Myriad Genetics case, observers are debating the impact of the outcome on personalized medicine and whole-genome sequencing
The new therapy for acute lymphoblastic leukemia, a swift-growing cancer that tends to kill more than 60 percent of those afflicted, involves extracting T cells and modifying them to home in on and destroy B cells in healthy and cancerous tissue...
New evidence suggests the mechanism of action for a red wine compound that some say is linked to a longer life span. Resveratrol acts directly on a protein that has been linked to cell metabolism and inflammatory diseases...
Revised guidelines for heart health are set to move away from target-based approach
The agency's approval of the first seasonal flu vaccine made of recombinant proteins rather than inactivated or weakened virus comes as emergency rooms are clogged with victims of an early and severe flu season...
Congress's decision on January 1 to delay mandatory cuts to agencies, including the NIH and NSF, means administrators must still plan for possible plunges in funding for medical schools and other campuses...
The drug industry says the antibiotic pipeline is blocked by overly stringent clinical-trial requirements for new treatments
Critics say controversy over publication of mutant-H5N1 research highlights biosecurity weaknesses